The way the world defines obesity has been in need of an overhaul, according to some experts, and it could be coming soon ...

A commission proposed a new definition of obesity focused on how excess fat affects the body, rather than assessing body mass ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

GLP-1 drugs have also demonstrated potential in reducing risks of several substance use disorders such as those involving alcohol, tobacco, cannabis, opioids and stimulants. This may be due to the ...

The study revealed that weight-loss drugs significantly benefit neurological and behavioral health, including decreased risks ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

New recommendations on how to define obesity would reduce the emphasis on body mass index and take into account health ...

BMI has long been considered a flawed measure that can over-diagnose or underdiagnose obesity, which is currently defined as ...

an obesity expert at the University of Washington and one of the 58 authors of the report published in The Lancet Diabetes & Endocrinology journal. The report introduces two new diagnostic ...

An international commission made the case for focusing on body fat quantity and the illnesses people experience.

Dr. David E. Cummings, a commissioner and professor of medicine at the University of Washington, told The Post that’s being ...